PBYI — Puma Biotechnology Inc · P/E 4.3, rev $56.5M

Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.

Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.

Use this PBYI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PBYI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PBYI SEC filings page. Lician reads the product cache first so this HTML stays unique to Puma Biotechnology Inc even when a live quote feed is slow.

Puma Biotechnology Inc latest statements (FY2025)

Latest cached year on this hub. Full PBYI income, balance, and cash tables.

  • Revenue$228.4M
  • Net Income$31.1M
  • Total Assets$216.3M
  • Total Debt$0
  • Free Cash Flow$41.7M